Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $4.6450 (-6.45%) ($4.6450 - $4.6450) on Thu. Aug. 11, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.11% (three month average) | RSI | 73 | Latest Price | $4.6450(-6.45%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 6.5% a day on average for past five trading days. | Weekly Trend | ATRA advances 18.4% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XLU(72%) LIT(68%) ACES(65%) ICLN(64%) SPLV(55%) | Factors Impacting ATRA price | ATRA will decline at least -5.055% in a week (0% probabilities). XOP(7%) TBT(-20%) UUP(-22%) USO(-9%) SHY(4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -5.055% (StdDev 10.11%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $4.28(8.53%) | 10 Day Moving Average | $3.72(24.87%) | 20 Day Moving Average | $3.58(29.75%) | To recent high | -47.1% | To recent low | 62.7% | Market Cap | $345m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |